Fair Value Measurements - Contingent Consideration (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2023 |
Dec. 31, 2022 |
Feb. 25, 2019 |
|
| Fair Value Measurements | |||
| Contingent consideration under RPAs and CPPAs | $ 125 | $ 75 | |
| Bioasis | Royalty Purchase Agreement | |||
| Fair Value Measurements | |||
| Changes in estimated fair value of contingent consideration | 0 | ||
| Contingent consideration under RPAs and CPPAs | $ 75 | $ 75 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Changes in estimated fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Liability recorded for contingent consideration under purchase agreements. May include royalty purchase agreements, commercial payment purchase agreements and payment interest purchase agreements. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|